EEG Prediction and Clinical Efficacy of tDCS in Major Depression
NCT: NCT07611773 · NOT_YET_RECRUITING
Brief Summary
The purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with major depression. As a secondary aim, we aim to assess the predictive value of baseline EEG for clinical response to high-dose home-based tDCS treatment in patients with major depression.
Frequently Asked Questions
What is EEG Prediction and Clinical Efficacy of tDCS in Major Depression?
EEG Prediction and Clinical Efficacy of tDCS in Major Depression is a clinical trial registered under NCT07611773. Current status: NOT_YET_RECRUITING.
What is the status of NCT07611773?
The current status of NCT07611773 (EEG Prediction and Clinical Efficacy of tDCS in Major Depression) is: NOT_YET_RECRUITING.
When did EEG Prediction and Clinical Efficacy of tDCS in Major Depression start?
EEG Prediction and Clinical Efficacy of tDCS in Major Depression started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.